UroLift in Place of Fiducial Markers for Patients With Benign Prostatic Hyperplasia Undergoing External Beam Radiation Therapy

Urology

Volumn 104, Issue , 2017, Pages 230-234

  Keehn, Aryeh ^a   Fram, Ethan ^a   Garg, Madhur ^a   Maria, Pedro ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICALUTAMIDE; LEUPRORELIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CYSTOSCOPE; CYSTOSCOPY; EXTERNAL BEAM RADIOTHERAPY; FIDUCIAL MARKER; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CLIP; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; MIDDLE AGED; NOCTURIA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; URINARY TRACT OBSTRUCTION; URINARY URGENCY; UROLIFT CLIP; UROLOGICAL SURGICAL EQUIPMENT; ADVERSE DEVICE EFFECT; COMPLICATION; MEDICAL RECORD; PROSTATE TUMOR; PROSTHESES AND ORTHOSES; TREATMENT OUTCOME; X RAY;

AGED; FIDUCIAL MARKERS; FOLLOW-UP STUDIES; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MEDICAL RECORDS; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; TREATMENT OUTCOME; X-RAYS;

EID: 85017387069     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2016.11.029     Document Type: Article

References (24)

1. Ray, A., Morgan, H., Wilkes, A., Carter, K., Carolan-Rees, G., The UroLift system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a NICE medical technology guidance. Appl Health Econ Health Policy 14 (2016), 515–526.
2. Garcia, C., Chin, P., Rashid, P., Woo, H.H., Prostatic urethral lift: a minimally invasive treatment for benign prostatic hyperplasia. Prostate Int 3 (2015), 1–5.
3. Chung, A., Woo, H.H., What's truly minimally invasive in benign prostatic hyperplasia surgery?. Curr Opin Urol 24 (2014), 36–41.
4. Roehrborn, C.G., Rukstalis, D.B., Barkin, J., et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 22 (2015), 7772–7782.
5. Ørsted, D.D., Bojesen, S.E., The link between benign prostatic hyperplasia and prostate cancer. Nat Rev Urol 10 (2013), 49–54.
6. Ørsted, D.D., Bojesen, S.E., Nielsen, S.F., Nordestgaard, B.G., Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men. Eur Urol 60 (2011), 691–698.
7. Rom, M., Waldert, M., Schatzl, G., Swietek, N., Shariat, S.F., Klatte, T., Bladder outlet obstruction (BOO) in men with castration-resistant prostate cancer. BJU Int 114 (2014), 62–66.
8. Attard, G., Parker, C., Eeles, R.A., et al. Prostate cancer. Lancet 387 (2016), 70–82.
9. Nomiya, T., Tsuji, H., Toyama, S., et al. Management of high-risk prostate cancer: radiation therapy and hormonal therapy. Cancer Treat Rev 39 (2013), 872–878.
10. Lumen, N., Ost, P., Van Praet, C., De meerleer, G., Villeirs, G., Fonteyne, V., Developments in external beam radiotherapy for prostate cancer. Urology 82 (2013), 5–10.
11. Ng, M., Brown, E., Williams, A., Chao, M., Lawrentschuk, N., Chee, R., Fiducial markers and spacers in prostate radiotherapy: current applications. BJU Int 113:suppl 2 (2014), 13–20.
12. Fransson, P., Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer—15 years' follow-up. A comparison with age-matched controls. Acta Oncol 47 (2008), 852–861.
13. Ponholzer, A., Brössner, C., Struhal, G., Marszalek, M., Madersbacher, S., Lower urinary tract symptoms, urinary incontinence, sexual function and quality of life after radical prostatectomy and external beam radiation therapy: real life experience in Austria. World J Urol 24 (2006), 325–330.
14. Woo, H.H., Chin, P.T., McNicholas, T.A., et al. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 108 (2011), 82–88.
15. Wang, J., Zhang, C., Tan, G., Chen, W., Yang, B., Tan, D., Risk of bleeding complications after preoperative antiplatelet withdrawal versus continuing antiplatelet drugs during transurethral resection of the prostate and prostate puncture biopsy: a systematic review and meta-analysis. Urol Int 89 (2012), 433–438.
16. Michaelson, M.D., Cotter, S.E., Gargollo, P.C., Zietman, A.L., Dahl, D.M., Smith, M.R., Management of complications of prostate cancer treatment. CA Cancer J Clin 58 (2008), 196–213.
17. Chin, P.T., Bolton, D.M., Jack, G., et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 79 (2012), 5–11.
18. Crook, J.M., Raymond, Y., Salhani, D., Yang, H., Esche, B., Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 37 (1995), 35–42.
19. Lei, S., Piel, N., Oermann, E.K., Chen, V., Ju, A.W., Dahal, K.N., Six-dimensional correction of intra-fractional prostate motion with CyberKnife stereotactic body radiation therapy. Front Oncol, 1, 2011, 48.
20. Schallenkamp, J.M., Herman, M.G., Kruse, J.J., Pisansky, T.M., Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 63 (2005), 800–811.
21. Herschorn, S., Elliott, S., Coburn, M., Wessells, H., Zinman, L., SIU/ICUD consultation on urethral strictures: posterior urethral stenosis after treatment of prostate cancer. Urology 83:3 suppl (2014), S59–S70.
22. Krupski, T.L., Stukenborg, G.J., Moon, K., Theodorescu, D., The relationship of palliative transurethral resection of the prostate with diseaseprogression in patients with prostate cancer. BJU Int 106 (2010), 1477–1483.
23. Marszalek, M., Ponholzer, A., Rauchenwald, M., Madersbacher, S., Palliative transurethral resection of the prostate: functional outcome and impact on survival. BJU Int 99 (2007), 56–59.
24. Mock, S., Leapman, M., Stock, R.G., Hall, S.J., Stone, N.N., Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters. J Urol 190 (2013), 1805–1810.